Literature DB >> 26924435

Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.

Jose Luis Olmos-Serrano1, Hyo Jung Kang2,3, William A Tyler1, John C Silbereis2, Feng Cheng2,4, Ying Zhu2, Mihovil Pletikos2, Lucija Jankovic-Rapan2, Nathan P Cramer5, Zygmunt Galdzicki5, Joseph Goodliffe1, Alan Peters1, Claire Sethares1, Ivana Delalle6, Jeffrey A Golden7, Tarik F Haydar1, Nenad Sestan2,8.   

Abstract

Trisomy 21, or Down syndrome (DS), is the most common genetic cause of developmental delay and intellectual disability. To gain insight into the underlying molecular and cellular pathogenesis, we conducted a multi-region transcriptome analysis of DS and euploid control brains spanning from mid-fetal development to adulthood. We found genome-wide alterations in the expression of a large number of genes, many of which exhibited temporal and spatial specificity and were associated with distinct biological processes. In particular, we uncovered co-dysregulation of genes associated with oligodendrocyte differentiation and myelination that were validated via cross-species comparison to Ts65Dn trisomy mice. Furthermore, we show that hypomyelination present in Ts65Dn mice is in part due to cell-autonomous effects of trisomy on oligodendrocyte differentiation and results in slower neocortical action potential transmission. Together, these results identify defects in white matter development and function in DS, and they provide a transcriptional framework for further investigating DS neuropathogenesis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  brain development; gene expression; genomics; glia; neocortex; neurodevelopmental disorders; white matter

Mesh:

Substances:

Year:  2016        PMID: 26924435      PMCID: PMC4795969          DOI: 10.1016/j.neuron.2016.01.042

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  58 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

2.  Anomalous brain morphology on magnetic resonance images in Williams syndrome and Down syndrome.

Authors:  T L Jernigan; U Bellugi
Journal:  Arch Neurol       Date:  1990-05

3.  Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function.

Authors:  L A Hyde; D F Frisone; L S Crnic
Journal:  Behav Brain Res       Date:  2001-01-08       Impact factor: 3.332

4.  The geometric structure of the brain fiber pathways.

Authors:  Van J Wedeen; Douglas L Rosene; Ruopeng Wang; Guangping Dai; Farzad Mortazavi; Patric Hagmann; Jon H Kaas; Wen-Yih I Tseng
Journal:  Science       Date:  2012-03-30       Impact factor: 47.728

Review 5.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

6.  Multiplex genetic fate mapping reveals a novel route of neocortical neurogenesis, which is altered in the Ts65Dn mouse model of Down syndrome.

Authors:  William A Tyler; Tarik F Haydar
Journal:  J Neurosci       Date:  2013-03-20       Impact factor: 6.167

7.  Motor skill learning requires active central myelination.

Authors:  Ian A McKenzie; David Ohayon; Huiliang Li; Joana Paes de Faria; Ben Emery; Koujiro Tohyama; William D Richardson
Journal:  Science       Date:  2014-10-17       Impact factor: 47.728

Review 8.  Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities.

Authors:  Noemí Rueda; Jesús Flórez; Carmen Martínez-Cué
Journal:  Neural Plast       Date:  2012-05-22       Impact factor: 3.599

9.  Label-free in vivo imaging of myelinated axons in health and disease with spectral confocal reflectance microscopy.

Authors:  Aaron J Schain; Robert A Hill; Jaime Grutzendler
Journal:  Nat Med       Date:  2014-03-30       Impact factor: 53.440

10.  Altered expression of immune-related genes in children with Down syndrome.

Authors:  Bruna Lancia Zampieri; Joice Matos Biselli-Périco; Jorge Estefano Santana de Souza; Matheus Carvalho Bürger; Wilson Araújo Silva Júnior; Eny Maria Goloni-Bertollo; Erika Cristina Pavarino
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

View more
  74 in total

1.  OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.

Authors:  Ranjie Xu; Andrew T Brawner; Shenglan Li; Jing-Jing Liu; Hyosung Kim; Haipeng Xue; Zhiping P Pang; Woo-Yang Kim; Ronald P Hart; Ying Liu; Peng Jiang
Journal:  Cell Stem Cell       Date:  2019-05-23       Impact factor: 24.633

Review 2.  Evolution of the Human Nervous System Function, Structure, and Development.

Authors:  André M M Sousa; Kyle A Meyer; Gabriel Santpere; Forrest O Gulden; Nenad Sestan
Journal:  Cell       Date:  2017-07-13       Impact factor: 41.582

3.  Quantitative MRI Analyses of Regional Brain Growth in Living Fetuses with Down Syndrome.

Authors:  Tomo Tarui; Kiho Im; Neel Madan; Rajeevi Madankumar; Brian G Skotko; Allie Schwartz; Christianne Sharr; Steven J Ralston; Rie Kitano; Shizuko Akiyama; Hyuk Jin Yun; Ellen Grant; Diana W Bianchi
Journal:  Cereb Cortex       Date:  2020-01-10       Impact factor: 5.357

4.  Multimodal Single-Cell Analysis Reveals Physiological Maturation in the Developing Human Neocortex.

Authors:  Simone Mayer; Jiadong Chen; Dmitry Velmeshev; Andreas Mayer; Ugomma C Eze; Aparna Bhaduri; Carlos E Cunha; Diane Jung; Arpana Arjun; Emmy Li; Beatriz Alvarado; Shaohui Wang; Nils Lovegren; Michael L Gonzales; Lukasz Szpankowski; Anne Leyrat; Jay A A West; Georgia Panagiotakos; Arturo Alvarez-Buylla; Mercedes F Paredes; Tomasz J Nowakowski; Alex A Pollen; Arnold R Kriegstein
Journal:  Neuron       Date:  2019-02-12       Impact factor: 17.173

Review 5.  Down syndrome and the complexity of genome dosage imbalance.

Authors:  Stylianos E Antonarakis
Journal:  Nat Rev Genet       Date:  2016-12-28       Impact factor: 53.242

Review 6.  Histone H2A Monoubiquitination in Neurodevelopmental Disorders.

Authors:  Anshika Srivastava; Brian McGrath; Stephanie L Bielas
Journal:  Trends Genet       Date:  2017-06-29       Impact factor: 11.639

7.  Down syndrome is accompanied by significantly reduced cortical grey-white matter tissue contrast.

Authors:  Anke Bletsch; Caroline Mann; Derek S Andrews; Eileen Daly; Giles M Y Tan; Declan G M Murphy; Christine Ecker
Journal:  Hum Brain Mapp       Date:  2018-06-08       Impact factor: 5.038

8.  The State of the NIH BRAIN Initiative.

Authors:  Walter Koroshetz; Joshua Gordon; Amy Adams; Andrea Beckel-Mitchener; James Churchill; Gregory Farber; Michelle Freund; Jim Gnadt; Nina S Hsu; Nicholas Langhals; Sarah Lisanby; Guoying Liu; Grace C Y Peng; Khara Ramos; Michael Steinmetz; Edmund Talley; Samantha White
Journal:  J Neurosci       Date:  2018-06-19       Impact factor: 6.167

9.  Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.

Authors:  Sarah E Lee; Monica Duran-Martinez; Sabina Khantsis; Diana W Bianchi; Faycal Guedj
Journal:  Trends Mol Med       Date:  2019-11-07       Impact factor: 11.951

10.  Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.

Authors:  Lisi Flores-Aguilar; M Florencia Iulita; Olivia Kovecses; Maria D Torres; Sarah M Levi; Yian Zhang; Manor Askenazi; Thomas Wisniewski; Jorge Busciglio; A Claudio Cuello
Journal:  Brain       Date:  2020-12-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.